Catalyst Pharma Q2 Loss Widens - Quick Facts

(RTTNews) - Catalyst Pharmaceutical Partners Inc. (CPRX) reported second-quarter net loss of $3.1 million or $0.08 per share, wider than $0.3 million or $0.01 per share in the comparable quarter last year.

Non-GAAP net loss for the latest second quarter widened to $2.6 million, or $0.06 per share, from $1.1 million, or $0.04 per share in the prior year quarter.

On average, two analysts polled by Thomson Reuters expected the company to report a loss of $0.07 per share. Analysts' estimates typically exclude special items.

As it is a development-stage specialty pharmaceutical company, it did not generate any revenue.